ID: hyp-SDA-2026-04-09-gap-debate-20260409-2
Hypothesis

Glycosyltransferase Modulation for Tau Vesicle Marking

Overexpression of specific glycosyltransferases (like MGAT5) creates 'glycan barcodes' on tau vesicles that recruit endogenous clearance machinery.
🧬 MGAT5🩺 neurodegeneration🎯 Composite 46%💱 $0.52▲6.0%active
EvidencePending (0%)📖 3 cit🗣 1 debates 3 support 1 oppose
✓ All Quality Gates Passed
Mechanistic 0.50 (15%) Evidence 0.50 (15%) Novelty 0.50 (12%) Feasibility 0.50 (12%) Impact 0.00 (12%) Druggability 0.50 (10%) Safety 0.50 (8%) Competition 0.50 (6%) Data Avail. 0.50 (5%) Reproducible 0.50 (5%) KG Connect 0.50 (8%) 0.455 composite

🧪 Overview

Overexpression of specific glycosyltransferases (like MGAT5) creates 'glycan barcodes' on tau vesicles that recruit endogenous clearance machinery. This approach would enhance the natural quality control systems by making pathological vesicles more recognizable to cellular degradation pathways.

🧬 Mechanism

🔗 Mechanism from KG for MGAT5

Auto-built from this analysis's top knowledge-graph edges.

graph TD
    MGAT5["MGAT5"] -->|catalyzes| N_glycosylation["N_glycosylation"]
    MGAT5_1["MGAT5"] -->|marks| tau_vesicles["tau_vesicles"]
    MGAT5_2["MGAT5"] -->|regulates| tau_aggregation["tau_aggregation"]
    MGAT5_3["MGAT5"] -->|modulates| tau_vesicle_recognition["tau_vesicle_recognition"]
    style MGAT5 fill:#ce93d8,stroke:#333,color:#000
    style N_glycosylation fill:#4fc3f7,stroke:#333,color:#000
    style MGAT5_1 fill:#ce93d8,stroke:#333,color:#000
    style tau_vesicles fill:#4fc3f7,stroke:#333,color:#000
    style MGAT5_2 fill:#ce93d8,stroke:#333,color:#000
    style tau_aggregation fill:#4fc3f7,stroke:#333,color:#000
    style MGAT5_3 fill:#ce93d8,stroke:#333,color:#000
    style tau_vesicle_recognition fill:#4fc3f7,stroke:#333,color:#000

⚖️ Evidence

⚖️ Evidence Matrix3 supports0 contradicts
Supports
The cancer-associated glycosyltransferase GnT-V (MGAT5) recognizes the N-glycan core via residues outside its catalytic pocket.
FEBS Lett2023PMID:37974463medium
Supports
N-glycosylation by Mgat5 imposes a targetable constraint on immune-mediated tumor clearance.
JCI Insight2024PMID:38912584medium
Supports
Reprogramming CD8+ T-cell Branched N-Glycosylation Limits Exhaustion, Enhancing Cytotoxicity and Tumor Killing.
Cancer Immunol Res2025PMID:40828448medium
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — MGAT5

No curated PDB or AlphaFold mapping for MGAT5 yet. Search RCSB →

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for MGAT5 →

No DepMap CRISPR Chronos data found for MGAT5.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▲ 0.0%
Volatility
High
0.0535
Events (7d)
0
Price History
▲6.0%

💾 Resource Usage

LLM Tokens
14,284
$0.0857
Total Cost
$0.0857

🔮 Predictions

🔎 Predictions vs Observations2 predictions · 0 with recorded observations
PredictionPredictedObservedStatusConf
IF MGAT5 is overexpressed via AAV-mediated gene delivery in the entorhinal cortex of 6-month-old MAPT P301S mice, THEN tau protein levels in hippocampal synaptosomes will decrease by ≥40% relative to ≥40% reduction in soluble and insoluble tau (AT8 epitope) in hippocampal synaptosomes at 12 weeks post-injection— no observation —pending0.62
IF MGAT5 is overexpressed in human iPSC-derived cortical neurons harboring P301L MAPT mutation, THEN the autophagic flux marker LC3-II/LC3-I ratio will increase by ≥50% and phospho-tau (AT8) will decr≥50% increase in LC3-II/LC3-I ratio and ≥35% decrease in AT8 phospho-tau after 21 days in culture— no observation —pending0.58
🔮 Falsifiable Predictions (2)
pendingconf 62%
IF MGAT5 is overexpressed via AAV-mediated gene delivery in the entorhinal cortex of 6-month-old MAPT P301S mice, THEN tau protein levels in hippocampal synaptosomes will decrease by ≥40% relative to AAV-empty vector controls within 12 weeks as measured by ELISA, because the MGAT5-created glycan bar
Predicted outcome: ≥40% reduction in soluble and insoluble tau (AT8 epitope) in hippocampal synaptosomes at 12 weeks post-injection
Falsification: No significant difference in tau levels between MGAT5-overexpressing and control groups (p>0.05), or increased tau aggregation/seeding capacity in the MGAT5 group
pendingconf 58%
IF MGAT5 is overexpressed in human iPSC-derived cortical neurons harboring P301L MAPT mutation, THEN the autophagic flux marker LC3-II/LC3-I ratio will increase by ≥50% and phospho-tau (AT8) will decrease by ≥35% within 21 days relative to P301L neurons transduced with empty vector, because MGAT5-me
Predicted outcome: ≥50% increase in LC3-II/LC3-I ratio and ≥35% decrease in AT8 phospho-tau after 21 days in culture
Falsification: No significant change in autophagic flux markers or phospho-tau levels (p>0.05), or evidence of endoplasmic reticulum stress/cell death increase in MGAT5-overexpressing neurons
Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesis
sourcev1_phase_c_backfill
origin_typedebate_synthesis
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.